PBIO News, Options Recaps

Pressure BioSciences, Inc. (OTCMKTS:PBIO)

First thing’s first today, we’ve got some fresh news out on PBIO that we wanted to pass along to our readers this morning. We sent out a report on PBIO yesterday that we would suggest you take a minute to go over now.

Today we are seeing the company release important info on the launch of its FDA-registered cannabis-enhanced, immune boosting prebiotic with proposed acquisition partner, Cannaworx

SOUTH EASTON, Mass., Dec. 4, 2020 /PRNewswire/ — Pressure BioSciences, Inc. (OTCMKTS: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced that its proposed acquisition partner Cannaworx, Inc. has set December 2020 as the commercial launch date for its patented immune booster supplement: ImmunaZin™.  Cannaworx believes that post-launch, this product will be one of very few OTC (over the counter), FDA registered, hemp seed oil-enhanced supplements with an immune booster claim. (>>View Full PR via OTCMARKETS)

Successful Options Review

We also formulated some fresh options ideas for yesterday’s session in our premarket report, and found some solid success in the case of the CRWD and SPLK chains.

Here are the total ranges and possible profits that could have been seized: 

CRWD Weekly $155-162.50 Calls
$155: 3.92-11.25 (+187%)
$157.50: 3.00-8.87 (+197%)
$160: 2.14-7.75 (+262%)
$162.50: 1.63-5.75 (+253%)

SPLK Weekly $170-160 Puts 
$170: 5.71-13.50 (+136%)
$165: 2.80-8.93 (+219%)
$160: 1.12-5.31 (+222%)

Fresh Options Ideas:
DOCU Weekly $242.50-247.50 Calls 
ULTA Weekly $275-282.50 Calls